Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 7Cognitive Dysfunction 4Neoplasms 3Stroke 2Pain 2Neurofibromatosis 1 2Fatigue 2Depression 2Cancer Pain 2Vomiting 1Spinal Cord Diseases 1Smoking Cessation 1Smoking 1Radiculopathy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Nausea 1Motor Activity 1Lymphoma, Follicular 1Hemianopsia 1Head and Neck Neoplasms 1Endometriosis 1Dyspareunia 1Dysmenorrhea 1Cognition Disorders 1Carcinoma, Hepatocellular 1Breast Cancer Survivors 1Brain Neoplasms 1Brain Injuries, Traumatic 1Bone Neoplasms 1

Interventions

Transcranial Direct Current Stimulation 2Magnetic Resonance Imaging 2gadolinium compound P760 1Waiting Lists 1Surveys and Questionnaires 1Neuropsychological Tests 1Lovastatin 1Lasers, Solid-State 1Lasers 1Genetic Testing 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neurofibromatosis 1 × Transcranial Direct Current Stimulation × Clear all
NCT04991428 2021-08-05

Mechanism of Action of Transcranial Direct Current Stimulation in Neurofibromatosis Type 1

University of Manchester

Phase NA Completed
31 enrolled
CNS

Neurofibromatosis 1

NCT03310996 2019-04-24

tDCS is NF1

University of Manchester

Phase NA Completed
16 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡